ISPC vs L · rev $9.3M vs P/E 14, rev $18.45B
iSpecimen Inc (ISPC) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
ISPC currently screens at market cap $4.4M. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the ISPC and L stock pages for the full models.
Not investment advice.